← Evidence map

ArticlePharmaceutics2019

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation.

Imco Sibum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31086107